Activation of ErbB2 and Downstream Signalling via Rho Kinases and ERK1/2 Contributes to Diabetes-Induced Vascular Dysfunction
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Activation of ErbB2 and Downstream Signalling via Rho Kinases and ERK1/2 Contributes to Diabetes-Induced Vascular Dysfunction
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 6, Pages e67813
Publisher
Public Library of Science (PLoS)
Online
2013-06-28
DOI
10.1371/journal.pone.0067813
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of Rosuvastatin on ROCK Activity, Endothelial Function, and Inflammation in Asian Patients with Atherosclerosis
- (2014) Ban Liu et al. INTERNAL MEDICINE
- Reactive oxygen species, Nox and angiotensin II in angiogenesis: implications for retinopathy
- (2013) Jennifer L. Wilkinson-Berka et al. CLINICAL SCIENCE
- Investigational therapies targeting the ErbB (EGFR, HER2, HER3, HER4) family in GI cancers
- (2013) Monica Dandona Desai et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Mechanisms of Diabetic Complications
- (2013) Josephine M. Forbes et al. PHYSIOLOGICAL REVIEWS
- Rho-kinase inhibition improves vasodilator responsiveness during hyperinsulinemia in the metabolic syndrome
- (2012) Francesca Schinzari et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Oxidative stress, Noxs, and hypertension: Experimental evidence and clinical controversies
- (2012) Augusto C. Montezano et al. ANNALS OF MEDICINE
- The Epidermal Growth Factor Receptor
- (2012) Tomonori Kobayashi et al. HYPERTENSION
- A Novel Role for Epidermal Growth Factor Receptor Tyrosine Kinase and Its Downstream Endoplasmic Reticulum Stress in Cardiac Damage and Microvascular Dysfunction in Type 1 Diabetes Mellitus
- (2012) Maria Galán et al. HYPERTENSION
- Molecular Mechanisms of Cardiotoxicity Induced by ErbB Receptor Inhibitor Cancer Therapeutics
- (2012) Anne-Sophie Hervent et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Fasudil, a Rho-kinase inhibitor, attenuates lipopolysaccharide-induced vascular hyperpermeability and colonic muscle relaxation in guinea pigs
- (2012) Kensuke Suzuki et al. JOURNAL OF SURGICAL RESEARCH
- Diabetes in numbers
- (2012) Tony Scully NATURE
- Activation of EGFR/ERBB2 via Pathways Involving ERK1/2, P38 MAPK, AKT and FOXO Enhances Recovery of Diabetic Hearts from Ischemia-Reperfusion Injury
- (2012) Saghir Akhtar et al. PLoS One
- Angiotensin II-induced vascular endothelial dysfunction through RhoA/Rho kinase/p38 mitogen-activated protein kinase/arginase pathway
- (2011) Alia Shatanawi et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Angiotensin-(1-7) inhibits epidermal growth factor receptor transactivation via a Mas receptor-dependent pathway
- (2011) Saghir Akhtar et al. BRITISH JOURNAL OF PHARMACOLOGY
- IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030
- (2011) David R. Whiting et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Diabetic cardiomyopathy—fact or fiction?
- (2011) B. Maisch et al. HERZ
- Aldosterone Stimulates the Cardiac Na + /H + Exchanger via Transactivation of the Epidermal Growth Factor Receptor
- (2011) Verónica C. De Giusti et al. HYPERTENSION
- Value of Angiotensin Receptor Blocker Therapy in Diabetes
- (2011) Joseph L. Izzo Jr et al. Journal of Clinical Hypertension
- Feedback regulation of EGFR signalling: decision making by early and delayed loops
- (2011) Roi Avraham et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Rho-associated coiled-coil-forming kinases (ROCKs): potential targets for the treatment of atherosclerosis and vascular disease
- (2011) Qian Zhou et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- The Vulnerability of the Heart As a Pluricellular Paracrine Organ
- (2010) Gilles W. De Keulenaer et al. CIRCULATION RESEARCH
- Oxidative Stress and Diabetic Complications
- (2010) Ferdinando Giacco et al. CIRCULATION RESEARCH
- Tyrosine Kinase Receptor Transactivation Associated to G Protein-Coupled Receptors
- (2010) Vanessa Almendro et al. CURRENT DRUG TARGETS
- Deficiency of Rac1 Blocks NADPH Oxidase Activation, Inhibits Endoplasmic Reticulum Stress, and Reduces Myocardial Remodeling in a Mouse Model of Type 1 Diabetes
- (2010) Jianmin Li et al. DIABETES
- Rho-kinase inhibition: a novel therapeutic target for the treatment of cardiovascular diseases
- (2010) Ming Dong et al. DRUG DISCOVERY TODAY
- EGF receptor activation by GPCRs: An universal pathway reveals different versions
- (2010) Claus Liebmann MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Lovastatin inhibits EGFR dimerization and AKT activation in squamous cell carcinoma cells: potential regulation by targeting rho proteins
- (2010) T T Zhao et al. ONCOGENE
- Betacellulin Induces Increased Retinal Vascular Permeability in Mice
- (2010) Bela Anand-Apte et al. PLoS One
- Targeting erbB receptors
- (2010) Zheng Cai et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Diabetes- and angiotensin II-induced cardiac endoplasmic reticulum stress and cell death: metallothionein protection
- (2009) Jiancheng Xu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Early inhibition of EGFR signaling prevents diabetes-induced up-regulation of multiple gene pathways in the mesenteric vasculature
- (2009) Ibrahim F. Benter et al. VASCULAR PHARMACOLOGY
- Rho Kinase Inhibition by Fasudil Ameliorates Diabetes-Induced Microvascular Damage
- (2008) R. Arita et al. DIABETES
- Elevated Epidermal Growth Factor Receptor Phosphorylation Induces Resistance Artery Dysfunction in Diabetic db/db Mice
- (2008) S. Belmadani et al. DIABETES
- EGFR Antagonists in Cancer Treatment
- (2008) Fortunato Ciardiello et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Intensive Glucose Lowering in Type 2 Diabetes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Gender differences in vascular reactivity to endothelin-1 (1-31) in mesenteric arteries from diabetic mice
- (2008) Takayuki Matsumoto et al. PEPTIDES
- Pharmacological Modulation of Epithelial Mesenchymal Transition Caused by Angiotensin II. Role of ROCK and MAPK Pathways
- (2008) Raquel Rodrigues-Díez et al. PHARMACEUTICAL RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now